Efficacy of Certolizumab Pegol in na ïve versus multi-treated patients affected by psoriatic arthritis.
CONCLUSIONS: Our results confirm that CZP can be administered safely and effectively to treat both psoriasis and psoriatic arthritis irrespective of previous treatments with biologic agents.
PMID: 33034437 [PubMed - as supplied by publisher]
Source: Giornale Italiano di Dermatologia e Venereologia - Category: Dermatology Tags: G Ital Dermatol Venereol Source Type: research
More News: Arthritis | Dermatology | Pain | Psoriasis | Psoriatic Arthritis | Rheumatology | Skin | Statistics